Save One Life, Inc. Welcomes Chris Bombardier, New Executive Director

GROVELAND, Mass., Jan. 14, 2019 /PRNewswire-PRWeb/ -- Save One Life, Inc. announces today a new executive director. Save One Life is an international nonprofit that assists people with hemophilia in developing countries. Christopher G. Bombardier, famous for being the first person with hemophilia to climb the Seven Summits, is taking the helm at the nonprofit for which he raised funds through his climbs.

Chris began his Seven Summits climbs in 2011 to raise awareness globally of the disparity in treatment for those with bleeding disorders in developed and developing countries. He has severe factor IX deficiency, also known as hemophilia B. Along the way, he joined the board of Save One Life, and raised over $100,000 dollars for the nonprofit

"I loved pushing myself mentally and physically throughout my climbs of the Seven Summits, but knowing that by reaching the summit I could bring more awareness and help to individuals living with bleeding disorders around the world inspired me in the most challenging moments," says Chris.

Chris, who is 33, joins a dynamic team that is eager to bring more care and funding to those in need in the 13 countries it serves. Chris is already well known around the world due to his successful climbs, particularly of Mt. Everest in 2017. He is eager to make successful and far-reaching changes to Save One Life. He brings to the job in-depth experience in leadership and team-building from his years working as a program facilitator with GutMonkey, an outdoor adventure leadership company. Chris is also earning a Master's degree in global health from Northwestern University, which will help him evolve and grow Save One Life's programs.

"I've known Chris since 2011, when we first talked about his idea to climb the Seven Summits," says founder Laurie Kelley. "He impressed me with his dedication and compassion, and stunned us with his achievements in reaching the summits. We helped support some of his climbs, and we believed in him from the start. We know he can take us to a whole new level at Save One Life."

"I'm excited to use my experiences in mountaineering, outdoor education and living with a chronic medical condition to better serve the mission and vision of Save One Life. We have an incredible team and I can't wait to see where we will be in the near future!"

Visit http://www.adventuresofahemophiliac.com to read more about Chris.
Visit http://www.saveonelife.net to learn more about Save One Life.

About Hemophilia
Hemophilia is an inherited blood-clotting disorder in which the blood is unable to form a clot. This is due to the absence of one of 13 sequential clotting proteins. Hemophilia A is a deficiency of factor VIII, and hemophilia B is a deficiency of factor IX. There are approximately 20,000 people with hemophilia in the US, and about 400,000 worldwide. People with hemophilia can bleed when injured or even spontaneously, with no known cause. They require frequent injections of commercial clotting factor to stop and prevent bleeds. Without these injections, they suffer joint damage and even death. It's estimated that 75% of people with hemophilia globally have little or no access to clotting factor medicine.

About Save One Life
Save One Life is a nonprofit that offers direct financial assistance to people with bleeding disorders in 13 developing countries. Hemophilia is a devastating inherited blood disorder that can still cause severe pain, crippling and even death when untreated. Developing countries usually cannot purchase the blood-clotting medicine needed to sustain life. People with hemophilia can be supported financially for only about a dollar a day. Save One Life offers direct sponsorships, scholarships, micro-enterprise grants and camp funding. Save One Life was founded in 2,000 by Laureen A. Kelley, author and president of LA Kelley Communications, and a mother of a child with hemophilia. For more information, visit http://www.saveonelife.net or call 978-352-7652.

SOURCE Save One Life, Inc.